Criticism Mounts Over Indonesia's Tobacco and E-Cigarette Regulations

Sep.29.2024
Criticism Mounts Over Indonesia's Tobacco and E-Cigarette Regulations
Indonesian Health Ministry's draft regulation on tobacco and e-cigarette safety management continues to draw criticism.

According to Kontan.Co.Id's report on September 28th, the draft of the Ministry of Health's Regulation on the Safety Management of Tobacco Products and E-Cigarettes (RPMK) in Indonesia continues to face criticism.


This policy is a follow-up measure to the "Law No. 17 of 2023" and the "Government Regulation No. 28 of 2024," but it is believed that during the drafting process, it did not fully involve all relevant departments and stakeholders.


Member of the ninth committee of the Indonesian parliament, Saleh Partaonan Daulay, expressed that while the parliament values health issues, they also do not want to overlook the interests of business and industry, as these areas are the responsibility of multiple departments including the Ministry of Trade, Ministry of Industry, and Ministry of Education, as schools are also affected. He questioned whether all relevant stakeholders were involved in the formulation of the RPMK, emphasizing that if they were not included, they may feel overlooked and potentially raise objections.


The chairman of the Indonesian Cigarette Manufacturers Association (Gaprindo), Benny Wachjudi, also expressed regret over this. He stated that as stakeholders in the industrial production sector, they were not invited to participate in the formulation of government regulations, and even in the final revision stage before the president's signing, several relevant departments did not sign. He added that the discussion should not only be based on health or industry perspectives, but must find a middle ground that can meet the needs of all parties.


Director of Public Relations and Service Bureau at the Ministry of Health, Siti Nadia Tarmizi, stated that they aim to control tobacco and other addictive substances, but will not prohibit people from smoking as it is a personal right.


One controversial clause in the RPMK pertains to packaging standardization. Article 5 of the draft stipulates that tobacco products must be packaged in Pantone 448 C color, and the branding, variety, and manufacturer information must be written in Indonesian.


Angga Handian Putra, a senior trade negotiation expert from the Ministry of Trade, stated that the Ministry of Health has not officially invited the Ministry of Trade to participate in the development of unified packaging policy. They found out about this proposal through the Ministry of Health's website, rather than through direct communication.


The Ministry of Commerce also warned that, in addition to challenges regarding brand trademarks, unified packaging policies may create trade barriers. Angga pointed out that scientific evidence should be provided to demonstrate that such policies can indeed improve public health and comply with the rules of the World Trade Organization (WTO). He urged the Ministry of Health to provide relevant scientific evidence and adhere to existing WTO regulations.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
Product | ELFBAR Launches New Open-System Device in UK with Three Pod Options and 2800mAh Battery
ELFBAR has launched its new open-system device ELFX MEGA, compatible with 2 mL, 5 mL and 10 mL pods and equipped with a 2800mAh battery that delivers significantly longer runtime than its predecessor. The device has passed MHRA notification in the UK and is now available online in the UK at a retail price of around £18.99.
Nov.25 by 2FIRSTS.ai
Selangor preparing regulatory policy that may gradually prohibit vape use
Selangor preparing regulatory policy that may gradually prohibit vape use
Selangor is drafting a policy paper outlining its regulatory direction for electronic cigarette products, including the possibility of gradually prohibiting vape use. The move aligns with the Tobacco Product Control Act for Public Health 2023 (Act 852) and aims to strengthen enforcement and youth health education.
Nov.21 by 2FIRSTS.ai
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04
 Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.
News
Dec.20
Philip Morris Korea: IQOS ILUMA i “SELETTI” Limited Edition Sells Out in One Week; Prime Model Sells Out on Launch Day
Philip Morris Korea: IQOS ILUMA i “SELETTI” Limited Edition Sells Out in One Week; Prime Model Sells Out on Launch Day
Philip Morris Korea and Italian design brand SELETTI’s limited “IQOS ILUMA i × SELETTI” collection sold out within one week of launch, with the “Prime” model selling out on its first day of release.
Nov.11 by 2FIRSTS.ai
U.S. vape firms appeal Mississippi synthetic-nicotine ban, citing FDA authority preemption
U.S. vape firms appeal Mississippi synthetic-nicotine ban, citing FDA authority preemption
A coalition of U.S. vape industry groups has appealed a Mississippi law banning the sale of e-cigarette products containing synthetic nicotine, arguing the statute effectively conditions sales on FDA authorization and unlawfully encroaches on federal regulatory authority. The law took effect in July 2025 and has already begun to be enforced.
Dec.17 by 2FIRSTS.ai